HLA-A*1101 & B2M & KRASG12C (VVVGACGVGK)

HLA-A*1101 & B2M & KRASG12C (VVVGACGVGK) Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag & Avi Tag (1)

  • Conjugate

    Biotin-labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
HLC-H82E7
Human
HEK293
Biotinylated Human HLA-A*11:01&B2M&KRASG12C (VVVGACGVGK) Complex Protein (Monomer, MALS verified)
Total: 1
  • 1

HLA-A*1101 & B2M & KRASG12C (VVVGACGVGK) Background

The Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) oncogene plays a critical role in the initiation and maintenance of pancreatic tumors and its signaling network represents a major target for therapeutic intervention. The Human HLA-A*1101 KRASG12V (VVVGAVGVGK) complex protein is a complex of HLA-A*1101 of the MHC Class I, B2M, and VVVGAV GVGK peptide of the KRASG12V.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
OMS-906OMS-906Phase 2 ClinicalUniversity Of Leicester, Medical Research Council, Helion Biotech APSHemoglobinuria, Paroxysmal; Glomerulonephritis
Details
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland